Literature DB >> 21692870

Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study.

G Serarslan1, N Savaş, J Z Yenin.   

Abstract

OBJECTIVE: We aimed to determine whether there was a difference between adult and paediatric alopecia areata patients with respect to the severity and pattern of the disease, nail changes and personal and family history of autoimmune diseases and also in comparison with controls.
METHODS: Two groups were included: patients with onset of alopecia before the age of ≤18 years and >18 years. The total number of the patients were 124. The control group was comprised of 114 age- and gender-matched patients.
RESULTS: There were 81 adults and 43 children. No statistically significant difference was present between disease severity and gender, age, personal and family history of autoimmune disease in the adult and paediatric group (P > 0.5). Thirteen adults with scalp involvement had nail changes. 61.5% had mild and 38.46% had severe disease (P > 0.5). Of the 43 paediatric patients, 10 patients had nail changes. Severe alopecia was present in 40% of patients with nail changes; however, 9.1% had severe alopecia in patients without nail changes (P = 0.04). There was no statistical significance in patients with and without familial autoimmune diseases when compared with pattern and severity of the diseases between the two groups.
CONCLUSION: The frequencies of autoimmune and atopic diseases were not different between adult and paediatric patients and the control group. We did not find a statistically significance between disease severity and personal and family history of autoimmune disease in the two groups. Disease severity was not related to nail changes in the adult group. However, severe alopecia areata was more prevalent in children with nail changes. Furthermore, ophiasis pattern was more prevalent in the paediatric group with nail changes compared with the adult group.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 21692870     DOI: 10.1111/j.1468-3083.2011.04152.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  The prevalence of systemic sclerosis is increased among patients with alopecia areata: a population-based study.

Authors:  Khalaf Kridin; Dana Tzur Bitan; Doron Comaneshter; Arnon D Cohen
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

2.  Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study.

Authors:  Khalaf Kridin; Guy Shalom; Doron Comaneshter; Arnon D Cohen
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

3.  The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review.

Authors:  Calvin T Sung; Franchesca D Choi; Margit Juhász; Natasha Atanaskova Mesinkovska
Journal:  Skin Appendage Disord       Date:  2019-02-26

4.  Differences in Comorbidity Profiles between Early-Onset and Late-Onset Alopecia Areata Patients: A Retrospective Study of 871 Korean Patients.

Authors:  Noo Ri Lee; Bo-Kyung Kim; Na Young Yoon; Sung-Yul Lee; Seok-Yong Ahn; Won-Soo Lee
Journal:  Ann Dermatol       Date:  2014-11-26       Impact factor: 1.444

5.  Severe subtype of alopecia areata is highly associated with thyroid autoimmunity.

Authors:  Ghada A Bin Saif
Journal:  Saudi Med J       Date:  2016-06       Impact factor: 1.484

6.  Association among Thyroid Dysfunction, Asthma, Allergic Rhinitis and Eczema in Children with Alopecia Areata.

Authors:  Javad Ghaffari; Ghasem Rahmatpour Rokni; Armaghan Kazeminejad; Hosein Abedi
Journal:  Open Access Maced J Med Sci       Date:  2017-06-11

7.  Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata.

Authors:  Kumutnart Chanprapaph; Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Kanchana Leerunyakul; Poonkiat Suchonwanit
Journal:  J Inflamm Res       Date:  2021-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.